GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Indegene Ltd

Indegene Ltd Incorporates Step-Down Wholly Owned Subsidiary in Portugal

M&A ● No Immediate Change LOW RISK
📅 Filed on BSE: 26 Oct 2026, 04:28 PM IST  ·  BSE ID: e43c933d-d86d-4468-ad01-14fd931234f5
View Original BSE Filing (PDF)
💡
In Simple Terms
The company created a new 100% owned subsidiary in Portugal to expand its international business.
🤖 AI Summary
  • Indegene Ltd's step-down wholly owned subsidiary, INDEGENE PORTUGAL, UNIPESSOAL LDA, was incorporated on October 23, 2026.
  • Indegene Ireland Limited, a wholly owned subsidiary, holds 100% of the share capital of the new entity.
  • The new subsidiary was established to expand Indegene Limited's presence in Portugal.
  • INDEGENE PORTUGAL, UNIPESSOAL LDA is yet to commence operations and currently reports Nil turnover.
  • The subsidiary will focus on services for life sciences, healthcare, and biopharmaceutical sectors.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Date of Incorporation
23 October 2026
Shareholding/Control Acquired
100%
Turnover of Subsidiary
Nil
🏢 How This Affects the Company
📈
Business Impact
The incorporation establishes a direct presence for Indegene Limited in the Portuguese market, allowing for future expansion in the life sciences and healthcare sectors.
💰
Financial Impact
The new subsidiary currently has Nil turnover as it is yet to begin operations, indicating no immediate financial impact on Indegene Limited.
⚙️
Operational Impact
The subsidiary will engage in services for life sciences, healthcare, biopharmaceutical sectors, and corporate support for affiliated entities, potentially diversifying the company's operational footprint.
⚠️
Risk Impact
The establishment of a new entity in a foreign jurisdiction introduces new operational and regulatory considerations in Portugal.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders.
👤
Who Is Affected
All shareholders are affected as the company expands its international footprint by incorporating a new subsidiary, which represents a strategic decision by management.
🔍
Management Signal
The management's decision to incorporate a new subsidiary in Portugal signals an intent to expand the company's global presence and service offerings.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Future disclosures regarding INDEGENE PORTUGAL, UNIPESSOAL LDA's operational commencement.
Upcoming quarterly results for updates on international business expansion efforts.
Any further details on investment or capital allocation towards the new Portuguese entity.
LOW RISK The filing reports the incorporation of a non-operational subsidiary, presenting minimal immediate risk to Indegene Limited.
💡 Investor Takeaway
Indegene Limited's wholly owned subsidiary, Indegene Ireland Limited, incorporated a 100% step-down wholly owned subsidiary, INDEGENE PORTUGAL, UNIPESSOAL LDA, on October 23, 2026, to establish a presence in Portugal. The new entity has Nil turnover as it is yet to commence operations.
⚖️ Strengths & Concerns

✅ Positives

  • Establishes a direct presence in Portugal, broadening Indegene Limited's geographic reach for future business development.
  • The new subsidiary aligns with Indegene Limited's core industry focus, providing services for life sciences and healthcare sectors.

⚠️ Concerns

  • The newly incorporated subsidiary is yet to begin operations and currently has Nil turnover, offering no immediate revenue contribution.
  • No specific cost of acquisition or consideration details were provided, limiting financial transparency regarding establishment expenses.
📅 Company Track Record
Recently listed — IPO March 2026. Limited public track record available. No previous filings related to acquisition or incorporation of new subsidiaries were found for Indegene Ltd.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the name of the new subsidiary incorporated by Indegene Limited?
The new step-down wholly owned subsidiary incorporated by Indegene Limited is named INDEGENE PORTUGAL, UNIPESSOAL LDA.
When was INDEGENE PORTUGAL, UNIPESSOAL LDA incorporated?
INDEGENE PORTUGAL, UNIPESSOAL LDA was incorporated on October 23, 2026.
What percentage of shareholding does Indegene Limited hold in the new Portuguese subsidiary?
Indegene Ireland Limited, a wholly owned subsidiary of Indegene Limited, holds 100% of the share capital of INDEGENE PORTUGAL, UNIPESSOAL LDA.
What is the current turnover of INDEGENE PORTUGAL, UNIPESSOAL LDA?
The current turnover of INDEGENE PORTUGAL, UNIPESSOAL LDA is Nil, as the entity is yet to begin operations.
What is the purpose of establishing the new subsidiary in Portugal?
The primary object and effect of the acquisition is to establish Indegene Limited's presence in Portugal, focusing on services for life sciences, healthcare, and biopharmaceutical sectors.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.